PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

about

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

Item

http://www.wikidata.org/entity/Q58623914

description

im November 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2008

@uk

name

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@en

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@nl

type

Item

label

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@en

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@nl

prefLabel

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@en

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@nl

P1476

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

@en

P2093

AM CÔTÉ

http://www.w3.org/2001/XMLSchema#string

J NEWSTEAD

http://www.w3.org/2001/XMLSchema#string

J NG

http://www.w3.org/2001/XMLSchema#string

LA MAGEE

http://www.w3.org/2001/XMLSchema#string

P VON DADELSZEN

http://www.w3.org/2001/XMLSchema#string

P2860

2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Historical Origins of the Health Belief Model

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.

Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

P304

271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0965539508002283

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

cardiovascular disease

pre-eclampsia